Cytomegalovirus viremia in solid organ transplantation: Does the initial viral load correlate with risk factors and outcomes?

Clinical Transplantation

Volumn 22, Issue 2, 2008, Pages 222-228

  Levitsky, Josh ^a   Freifeld, Alison G ^b   Puumala, Susan ^c   Bargenquast, Kim ^b   Hardiman, Penny ^b   Gebhart, Catherine ^d   Wrenshall, Lucy ^e   Langnas, Alan ^e   Kalil, Andre C ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c Department of Preventive and Societal Medicine ^*  (United States)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS; VALACICLOVIR; VALGANCICLOVIR;

ADJUVANT THERAPY; ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; FEMALE; GRAFT REJECTION; HUMAN; MALE; MONOTHERAPY; ORGAN TRANSPLANTATION; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE STUDY; RISK FACTOR; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK FACTORS; TRANSPLANTS; TREATMENT OUTCOME; VIRAL LOAD; VIREMIA;

EID: 41049111211     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2007.00778.x     Document Type: Article

References (23)

1. Winston DJ, Emmanouilides C, Busuttil RW. Infections in liver transplant recipients. Clin Infect Dis 1995: 21: 1077.
2. Limaye AP, Bakthavatsalam R, Kim HW et al. Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis. Transplantation 2004: 78: 1390.
3. Singh N. Cytomegalovirus infection in solid organ transplant recipients: New challenges and their implications for preventive strategies. J Clin Virol 2006: 35: 474.
4. Rubin RH. Cytomegalovirus infection in the liver transplant recipient. Epidemiology, pathogenesis, and clinical management. Clin Liver Dis 1997: 1: 439.
5. Singh N. Cytomegalovirus infection of liver transplant recipients: comparison of antigenemia and molecular biology assays. Liver Transpl 2001: 7: 1004.
6. Schmidt CA, Oettle H, Peng R et al. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation. Transplantation 1995: 59: 1133.
7. Drouet E, Colimon R, Michelson S et al. Monitoring levels of human cytomegalovirus DNA in blood after liver transplantation. J Clin Microbiol 1995: 33: 389.
8. Mendez J, Espy M, Smith TF, Wilson J, Wiesner R, Paya CV. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation 1998: 65: 1477.
9. Humar A, Gregson D, Caliendo AM et al. Clinical utility of quantitative cytomegalovirus viral load determination for predicting cytomegalovirus disease in liver transplant recipients. Transplantation 1999: 68: 1305.
10. Piiparinen H, Hockerstedt K, Lappalainen M, Suni J, Lautenschlager I. Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients. J Clin Microbiol 2002: 40: 2945.
11. Lilleri D, Baldanti F, Gatti M et al. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J Med Virol 2004: 73: 412.
12. Ghisetti V, Barbui A, Franchello A et al. Quantitation of cytomegalovirus DNA by the polymerase chain reaction as a predictor of disease in solid organ transplantation. J Med Virol 2004: 73: 223.
13. Humar A, Paya C, Pescovitz MD et al. Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R-solid organ transplant recipients. Am J Transplant 2004: 4: 644.
14. Fisher RA, Saggi BH, Ferreira-Gonzalez A, Wolfe L, Posner MP. Prospective validation of quantitative polymerase chain reaction for management of cytomegalovirus disease in solid-organ transplant patients. Transplantation 2002: 74: 573.
15. Sia IG, Wilson JA, Groettum CM, Espy MJ, Smith TF, Paya CV. Cytomegalovirus (CMV) DNA load predicts relapsing CMV infection after solid organ transplantation. J Infect Dis 2000: 181: 717.
16. Weng FL, Patel AM, Wanchoo R et al. Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants. Transplantation 2007: 15: 83.
17. Humar A, Michaels M. AST ID Working Group on Infectious Disease Monitoring. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006: 6: 262.
18. Kalil AC, Levitsky J, Lyden E, Stoner J, Freifeld AG. Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005: 143: 870.
19. Falagas ME, Snydman DR. Recurrent cytomegalovirus disease in solid-organ transplant recipients. Transplant Proc 1995: 27: 34.
20. Falagas ME, Snydman DR, Griffith J, Werner BG, Freeman R, Rohrer R. Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston center for liver transplantation CMVIG study group. Clin Infect Dis 1997: 25: 314.
21. Sawyer MD, Mayoral JL, Gillingham KJ, Kramer MA, Dunn DL. Treatment of recurrent cytomegalovirus disease in patients receiving solid organ transplants. Arch Surg 1993: 128: 165.
22. Singhal S, Shaw JC, Ainsworth J et al. Direct visualization and quantitation of cytomegalovirus-specific CD8+ cytotoxic T-lymphocytes in liver transplant patients. Transplantation 2000: 69: 2251.
23. Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 1997: 89: 3873.